Established in 2021, Braidwell LP is an investment firm based in Stamford, Connecticut, specializing in biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm invests across public, private, and structured capital markets, utilizing both long and short-equity strategies.
As the Co-Founder and Chief Investment Officer of Braidwell, Alex Karnal spearheads the firm's commitment to investing in assets and organizations at the forefront of medicine, science, and technology to enhance human well-being. Before co-founding Braidwell, Alex served as a Partner, Managing Director, and Co-Portfolio Manager at Deerfield from 2005 to 2021. He earned a B.S. from the Massachusetts Institute of Technology and an M.S. from Johns Hopkins University.
Braidwell, a hedge fund serving 8 clients, manages discretionary assets totaling $4,620,687,889, as per their Form ADV filed on April 3, 2023. Their latest 13F filing for Q4 2023 revealed $2,722,670,757 in managed 13F securities, with a top 10 holdings concentration of 40.29%. The fund's most substantial holding is GUARDANT HEALTH INC NOTE 11/1, with 268,252,000 shares held.
